Expression of genes involved in lipogenesis is not increased in patients with HCV genotype 3 in human liver

Journal of Viral Hepatitis

Volumn 18, Issue 1, 2011, Pages 53-60

  Ryan, M C ^a,b   Desmond, P V ^a,b   Slavin, J L ^a   Congiu, M ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

genotype 3; HCV; liver; PPARA; SREBF1; steatosis

Indexed keywords

ACETYL COENZYME A; APOLIPOPROTEIN B; ARGININE; BETA GLUCURONIDASE; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE AMP ACTIVATED ALPHA 1; PYRUVATE DECARBOXYLASE; SERINE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; FATTY LIVER; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIPOGENESIS; LIVER BIOPSY; LIVER FIBROSIS; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; FATTY LIVER; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; PPAR ALPHA; PROTEINS; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UP-REGULATION;

EID: 78149439794     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2010.01283.x     Document Type: Article

References (45)

1. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714. (Pubitemid 46780630)
2. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G,. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33: 1358-1364. (Pubitemid 32496971)
3. Cross TJ, Quaglia A, Hughes S, Joshi D, Harrison PM,. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection. J Viral Hepat 2009; 16: 492-499.
4. Alonzi T, Agrati C, Costabile B, et al. Steatosis and intrahepatic lymphocyte recruitment in hepatitis C virus transgenic mice. J Gen Virol 2004; 85: 1509-1520. (Pubitemid 38807748)
5. Kapadia SB, Chisari FV,. Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids. Proc Natl Acad Sci USA 2005; 102: 2561-2566.
6. Chang ML, Yeh CT, Chen JC, et al. Altered expression patterns of lipid metabolism genes in an animal model of HCV core-related, nonobese, modest hepatic steatosis. BMC Genomics. 2008; 9: 109.
7. Kim KH, Hong SP, Kim K, Park MJ, Kim KJ, Cheong J,. HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma. Biochem Biophys Res Commun 2007; 355: 883-888. (Pubitemid 46366910)
8. Yang W, Hood BL, Chadwick SL, et al. Fatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and production. Hepatology 2008; 48: 1396-1403.
9. Waris G, Felmlee DJ, Negro F, Siddiqui A,. Hepatitis C virus induces proteolytic cleavage of sterol regulatory element binding proteins and stimulates their phosphorylation via oxidative stress. J Virol 2007; 81: 8122-8130. (Pubitemid 47101498)
10. Jackel-Cram C, Babiuk LA, Liu Q,. Up-regulation of fatty acid synthase promoter by hepatitis C virus core protein: genotype-3a core has a stronger effect than genotype-1b core. J Hepatol 2007; 46: 999-1008. (Pubitemid 46669729)
11. Park CY, Jun HJ, Wakita T, Cheong JH, Hwang SB,. Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 2009; 284: 9237-9246.
12. Abid K, Pazienza V, De GottardiA, et al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation. J Hepatol 2005; 42: 744-751. (Pubitemid 40501692)
13. Piodi A, Chouteau P, Lerat H, Hézode C, Pawlotsky JM,. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis. Hepatology 2008; 48: 16-27. (Pubitemid 351975527)
14. Fukasawa M, Tanaka Y, Sato S, et al. Enhancement of de novo fatty acid biosynthesis in hepatic cell line Huh7 expressing hepatitis C virus core protein. Biol Pharm Bull 2006; 29: 1958-1961. (Pubitemid 44338426)
15. Oem JK, Jackel-Cram C, Li YP, et al. Activation of sterol regulatory element-binding protein 1c and fatty acid synthase transcription by hepatitis C virus non-structural protein 2. J Gen Virol 2008; 89: 1225-1230.
16. Perlemuter G, Sabile A, Letteron P, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis. FASEB J 2002; 16: 185-194. (Pubitemid 34113012)
17. Mirandola S, Realdon S, Iqbal J, et al. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Gastroenterology 2006; 130: 1661-1669. (Pubitemid 43668848)
18. Yamaguchi A, Tazuma S, Nishioka T, et al. Hepatitis C virus core protein modulates fatty acid metabolism and thereby causes lipid accumulation in the liver. Dig Dis Sci 2005; 50: 1361-1371. (Pubitemid 41184770)
19. Cheng Y, Dharancy S, Malapel M, Desreumaux P,. Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A. World J Gastroenterol 2005; 11: 7591-7596. (Pubitemid 43168421)
20. Dharancy S, Malapel M, Perlemuter G, et al. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 2005; 128: 334-342. (Pubitemid 40431087)
21. Tanaka N, Moriya K, Kiyosawa K, Koike K, Gonzalez FJ, Aoyama T,. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J Clin Invest 2008; 118: 683-694. (Pubitemid 351206557)
22. McPherson S, Jonsson JR, Barrie HD, O'Rourke P, Clouston AD, Powell EE,. Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis. J Hepatol 2008; 49: 1046-1054.
23. Congiu M, Mashford ML, Slavin JL, Desmond PV,. UDP glucuronosyltransferase mRNA levels in human liver disease. Drug Metab Dispos 2002; 30: 129-134. (Pubitemid 34106530)
24. Hall TA,. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41: 95-98.
25. Bedossa P, Poynard T,. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-293.
26. Brunt EM, Janney CG, Di BisceglieAM, Neuschwander-Tetri BA, Bacon BR,. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474. (Pubitemid 29420675)
27. Améen C, Edvardsson U, Ljungberg A, et al. Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver. J Biol Chem 2005; 280: 1224-1229.
28. Kim HJ, Takahashi M, Ezaki O,. Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipogenic enzyme mRNAs. J Biol Chem 1999; 274: 25892-25898. (Pubitemid 129530770)
29. Rakic B, Sagan SM, Noestheden M, et al. Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication. Chem Biol 2006; 13: 23-30. (Pubitemid 43099921)
30. Avramoglu RK, Adeli K,. Hepatic regulation of apolipoprotein B. Rev Endocr Metab Disord 2004; 5: 293-301. (Pubitemid 39388747)
31. Lindén D, Lindberg K, Oscarsson J, et al. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. J Biol Chem 2002; 277: 23044-23053. (Pubitemid 34967291)
32. Gudbrandsen OA, Rost TH, Berge RK,. Causes and prevention of tamoxifen-induced accumulation of triacylglycerol in rat liver. J Lipid Res 2006; 47: 2223-2232.
33. Ogawa Y, Murata Y, Saibara T, et al. Follow-up CT findings of tamoxifen-induced non-alcoholic steatohepatitis (NASH) of breast cancer patients treated with bezafibrate. Oncol Rep 2003; 10: 1473-1478.
34. Fujita N, Kaito M, Kai M, et al. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin. J Viral Hepat 2006; 13: 441-448. (Pubitemid 43911753)
35. Kita R, Takamatsu S, Kimura T, Kokuryu H, Osaki Y, Tomono N,. Bezafibrate may attenuate biliary damage associated with chronic liver diseases accompanied by high serum biliary enzyme levels. J Gastroenterol 2006; 41: 686-692. (Pubitemid 44288534)
36. Rozema DB, Lewis DL, Wakefield DH, et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc Natl Acad Sci USA 2007; 104: 12982-12987. (Pubitemid 351737577)
37. De Souza AT, Dai X, Spencer AG, et al. Transcriptional and phenotypic comparisons of Ppara knockout and siRNA knockdown mice. Nucleic Acids Res 2006; 34: 4486-4494. (Pubitemid 44567048)
38. Yin HQ, Kim M, Kim JH, et al. Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice. Toxicol Appl Pharmacol 2007; 223: 225-233. (Pubitemid 47371140)
39. Fimia GM, Tripodi M, Alonzi T,. Transgenic models for Hepatitis C virus pathogenesis. Cell Death Differ 2003; 10: S16-S18. (Pubitemid 36511847)
40. Pazienza V, Clément S, Pugnale P, et al. Gene expression profile of Huh-7 cells expressing hepatitis C virus genotype 1b or 3a core proteins. Liver Int 2009; 29: 661-669.
41. Domitrovich AM, Felmlee DJ, Siddiqui A,. Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion. J Biol Chem 2005; 280: 39802-39808. (Pubitemid 41779113)
42. Boonstra A, Van DerLaanLJ, Vanwolleghem T, Janssen HL,. Experimental models for hepatitis C viral infection. Hepatology 2009; 50: 1-10.
43. Bigger CB, Guerra B, Brasky KM, et al. Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees. J Virol 2004; 78: 13779-13792. (Pubitemid 39612775)
44. Su AI, Pezacki JP, Wodicka L, et al. Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci USA 2002; 99: 15669-15674. (Pubitemid 35403989)
45. Zhou J, Zhai Y, Mu Y, et al. A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway. J Biol Chem 2006; 281: 15013-15020. (Pubitemid 43855205)